• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-氨基酸氧化酶在腹侧被盖区表达并调节皮质多巴胺。

D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine.

机构信息

Department of Psychiatry, University of Oxford Oxford, UK ; Department of Pharmacology, University of Oxford Oxford, UK.

Department of Psychiatry, University of Oxford Oxford, UK.

出版信息

Front Synaptic Neurosci. 2014 May 2;6:11. doi: 10.3389/fnsyn.2014.00011. eCollection 2014.

DOI:10.3389/fnsyn.2014.00011
PMID:24822045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4014674/
Abstract

D-amino acid oxidase (DAO, DAAO) degrades the NMDA receptor co-agonist D-serine, modulating D-serine levels and thence NMDA receptor function. DAO inhibitors are under development as a therapy for schizophrenia, a disorder involving both NMDA receptor and dopaminergic dysfunction. However, a direct role for DAO in dopamine regulation has not been demonstrated. Here, we address this question in two ways. First, using in situ hybridization and immunohistochemistry, we show that DAO mRNA and immunoreactivity are present in the ventral tegmental area (VTA) of the rat, in tyrosine hydroxylase (TH)-positive and -negative neurons, and in glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes. Second, we show that injection into the VTA of sodium benzoate, a DAO inhibitor, increases frontal cortex extracellular dopamine, as measured by in vivo microdialysis and high performance liquid chromatography. Combining sodium benzoate and D-serine did not enhance this effect, and injection of D-serine alone affected dopamine metabolites but not dopamine. These data show that DAO is expressed in the VTA, and suggest that it impacts on the mesocortical dopamine system. The mechanism by which the observed effects occur, and the implications of these findings for schizophrenia therapy, require further study.

摘要

D-氨基酸氧化酶(DAO,DAAO)降解 NMDA 受体共激动剂 D-丝氨酸,调节 D-丝氨酸水平,从而调节 NMDA 受体功能。DAO 抑制剂作为精神分裂症的一种治疗方法正在开发中,精神分裂症是一种涉及 NMDA 受体和多巴胺能功能障碍的疾病。然而,DAO 在多巴胺调节中的直接作用尚未得到证实。在这里,我们通过两种方法来解决这个问题。首先,通过原位杂交和免疫组织化学,我们表明 DAO mRNA 和免疫反应性存在于大鼠腹侧被盖区(VTA)中,存在于酪氨酸羟化酶(TH)阳性和阴性神经元中,以及胶质纤维酸性蛋白(GFAP)免疫反应性星形胶质细胞中。其次,我们表明,将 DAO 抑制剂苯甲酸钠注射到 VTA 中会增加前额皮质细胞外多巴胺,这是通过体内微透析和高效液相色谱法测量的。将苯甲酸钠和 D-丝氨酸联合使用并没有增强这种效果,而单独注射 D-丝氨酸会影响多巴胺代谢物,但不会影响多巴胺。这些数据表明 DAO 在 VTA 中表达,并表明它影响中皮质多巴胺系统。观察到的效应发生的机制,以及这些发现对精神分裂症治疗的意义,需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/dbac7a5a369e/fnsyn-06-00011-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/c0483a797475/fnsyn-06-00011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/184eb4bbce58/fnsyn-06-00011-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/dbac7a5a369e/fnsyn-06-00011-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/c0483a797475/fnsyn-06-00011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/184eb4bbce58/fnsyn-06-00011-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8127/4014674/dbac7a5a369e/fnsyn-06-00011-g0003.jpg

相似文献

1
D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine.D-氨基酸氧化酶在腹侧被盖区表达并调节皮质多巴胺。
Front Synaptic Neurosci. 2014 May 2;6:11. doi: 10.3389/fnsyn.2014.00011. eCollection 2014.
2
Increased burst-firing of ventral tegmental area dopaminergic neurons in D-amino acid oxidase knockout mice in vivo.D-氨基酸氧化酶基因敲除小鼠体内腹侧被盖区多巴胺能神经元的爆发式放电增加。
Eur J Neurosci. 2014 Oct;40(7):2999-3009. doi: 10.1111/ejn.12667. Epub 2014 Jul 5.
3
The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain.中脑皮质多巴胺能神经元的药理学:大鼠脑腹侧被盖区和前额叶皮质的双探针微透析研究
J Pharmacol Exp Ther. 1998 Apr;285(1):143-54.
4
Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.用D-氨基酸氧化酶抑制剂调节NMDA受体功能:了解苯环利定处理小鼠模型中的功能活性
Neurochem Res. 2016 Feb;41(1-2):398-408. doi: 10.1007/s11064-016-1838-8. Epub 2016 Feb 8.
5
Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain.D-氨基酸氧化酶在精神分裂症中的潜在病理生理学作用:人类和大鼠脑组织中表达的免疫组织化学和原位杂交研究。
J Neural Transm (Vienna). 2009 Oct;116(10):1335-47. doi: 10.1007/s00702-009-0289-7. Epub 2009 Aug 15.
6
Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity.星形胶质细胞D-氨基酸氧化酶在细胞外D-丝氨酸代谢和细胞毒性中的潜在作用。
J Biochem. 2006 Feb;139(2):295-304. doi: 10.1093/jb/mvj036.
7
Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens.向腹侧海马体注射N-甲基-D-天冬氨酸会增加腹侧被盖区和伏隔核中的细胞外多巴胺水平。
Synapse. 1999 Mar 15;31(4):241-9. doi: 10.1002/(SICI)1098-2396(19990315)31:4<241::AID-SYN1>3.0.CO;2-#.
8
Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.苯甲酸钠和 PGM030756 两种 D-氨基酸氧化酶抑制剂的靶标结合和 D-丝氨酸生物标志物特征评估。
Neurochem Res. 2017 Nov;42(11):3279-3288. doi: 10.1007/s11064-017-2367-9. Epub 2017 Aug 5.
9
Stimulation of glutamate receptors in the ventral tegmental area is necessary for serotonin-2 receptor-induced increases in mesocortical dopamine release.腹侧被盖区谷氨酸受体的刺激对于5-羟色胺2型受体诱导的中皮质多巴胺释放增加是必要的。
Neuroscience. 2015 Apr 2;290:159-64. doi: 10.1016/j.neuroscience.2015.01.029. Epub 2015 Jan 28.
10
Role for D-serine within the ventral tegmental area in the development of cocaine's sensitization.腹侧被盖区中的D-丝氨酸在可卡因敏化发展中的作用。
Neuropsychopharmacology. 2008 Apr;33(5):995-1003. doi: 10.1038/sj.npp.1301495. Epub 2007 Jul 4.

引用本文的文献

1
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.D-氨基酸治疗抵抗性精神分裂症的合理性和转化意义:从神经生物学到临床。
Biomolecules. 2022 Jun 29;12(7):909. doi: 10.3390/biom12070909.
2
Sodium Benzoate-Harmfulness and Potential Use in Therapies for Disorders Related to the Nervous System: A Review.苯甲酸钠的危害及其在神经系统相关疾病治疗中的潜在用途:综述。
Nutrients. 2022 Apr 2;14(7):1497. doi: 10.3390/nu14071497.
3
Exome Sequencing Identifies A Nonsense Variant in DAO Associated With Reduced Energy Expenditure in American Indians.

本文引用的文献

1
Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine.D-氨基酸氧化酶中与肌萎缩侧索硬化症相关的突变的致病作用由D-丝氨酸介导。
Neurobiol Aging. 2014 Apr;35(4):876-85. doi: 10.1016/j.neurobiolaging.2013.09.005. Epub 2013 Oct 15.
2
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.苯甲酸盐辅助治疗精神分裂症:D-氨基酸氧化酶抑制剂的随机、双盲、安慰剂对照试验。
JAMA Psychiatry. 2013 Dec;70(12):1267-75. doi: 10.1001/jamapsychiatry.2013.2159.
3
Retinal NMDA receptor function and expression are altered in a mouse lacking D-amino acid oxidase.
外显子组测序鉴定出与美洲印第安人能量消耗减少相关的 DAO 无义变异。
J Clin Endocrinol Metab. 2020 Nov 1;105(11):e3989-4000. doi: 10.1210/clinem/dgaa548.
4
Positive effects of systemic sodium benzoate and olanzapine treatment on activities of daily life, spatial learning and working memory in ketamine-induced rat model of schizophrenia.系统性苯甲酸钠和奥氮平治疗对氯胺酮诱导的大鼠精神分裂症模型的日常生活活动、空间学习和工作记忆的积极影响。
Int J Physiol Pathophysiol Pharmacol. 2019 Apr 15;11(2):21-30. eCollection 2019.
5
Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-)) mice.在莫里斯水迷宫中寻找认知增强作用:D-氨基酸氧化酶基因敲除(Dao(-/-))小鼠的表现有优有劣。
Eur J Neurosci. 2016 Apr;43(7):979-89. doi: 10.1111/ejn.13192. Epub 2016 Mar 23.
6
d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption.d- 氨基酸氧化酶敲除(Dao(-/-) )小鼠表现出增强的短期记忆表现和更高的焦虑,但没有睡眠或昼夜节律紊乱。
Eur J Neurosci. 2015 May;41(9):1167-79. doi: 10.1111/ejn.12880. Epub 2015 Mar 27.
7
Evidence for limited D1 and D2 receptor coexpression and colocalization within the dorsal striatum of the neonatal mouse.新生小鼠背侧纹状体内D1和D2受体共表达及共定位有限的证据。
J Comp Neurol. 2015 Jun 1;523(8):1175-89. doi: 10.1002/cne.23730. Epub 2015 Feb 17.
在缺乏 D-氨基酸氧化酶的小鼠中,视网膜 NMDA 受体功能和表达发生改变。
J Neurophysiol. 2013 Dec;110(12):2718-26. doi: 10.1152/jn.00310.2013. Epub 2013 Sep 25.
4
The second revision of the dopamine theory of schizophrenia: implications for treatment and drug development.精神分裂症多巴胺理论的第二次修订:对治疗和药物开发的启示。
Biol Psychiatry. 2013 Jul 15;74(2):80-1. doi: 10.1016/j.biopsych.2013.05.016.
5
NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies.精神分裂症患者血清、血浆和脑脊液中 NMDA 受体共激动剂:病例对照研究的荟萃分析。
Neurosci Biobehav Rev. 2013 Sep;37(8):1587-96. doi: 10.1016/j.neubiorev.2013.06.007. Epub 2013 Jun 18.
6
D-serine as a gliotransmitter and its roles in brain development and disease.D-丝氨酸作为一种神经递质及其在大脑发育和疾病中的作用。
Front Cell Neurosci. 2013 Apr 23;7:39. doi: 10.3389/fncel.2013.00039. eCollection 2013.
7
D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.D-氨基酸氧化酶抑制剂作为一种新型抗精神分裂症药物。
Curr Pharm Des. 2013;19(14):2499-511. doi: 10.2174/1381612811319140002.
8
NMDA receptor and schizophrenia: a brief history.NMDA 受体与精神分裂症:简要的历史。
Schizophr Bull. 2012 Sep;38(5):920-6. doi: 10.1093/schbul/sbs076.
9
D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.脑内 D-氨基酸和缺乏 D-氨基酸氧化酶活性的突变鼠。
Amino Acids. 2012 Nov;43(5):1811-21. doi: 10.1007/s00726-012-1384-x. Epub 2012 Aug 15.
10
Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.突触和 extrasynaptic NMDA 受体由不同的内源性共激动剂门控。
Cell. 2012 Aug 3;150(3):633-46. doi: 10.1016/j.cell.2012.06.029.